Karlén P - Search Results

1

Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease.

Lindberg A, Eberhardson M, Karlsson M, Karlén P. Lindberg A, et al. Among authors: karlen p. BMC Gastroenterol. 2010 Jul 6;10:73. doi: 10.1186/1471-230X-10-73. BMC Gastroenterol. 2010. PMID: 20604939 Free PMC article.

2

DNA aneuploidy in ulcerative colitis: reproducibility, topographic distribution, and relation to dysplasia.

Löfberg R, Broström O, Karlén P, Ost A, Tribukait B. Löfberg R, et al. Among authors: karlen p. Gastroenterology. 1992 Apr;102(4 Pt 1):1149-54. Gastroenterology. 1992. PMID: 1551524

3

Colonoscopic surveillance in long-standing total ulcerative colitis--a 15-year follow-up study.

Löfberg R, Broström O, Karlén P, Tribukait B, Ost A. Löfberg R, et al. Among authors: karlen p. Gastroenterology. 1990 Oct;99(4):1021-31. doi: 10.1016/0016-5085(90)90622-8. Gastroenterology. 1990. PMID: 2394325

4

Crohn's disease and cancer: a population-based cohort study.

Persson PG, Karlén P, Bernell O, Leijonmarck CE, Broström O, Ahlbom A, Hellers G. Persson PG, et al. Among authors: karlen p. Gastroenterology. 1994 Dec;107(6):1675-9. doi: 10.1016/0016-5085(94)90807-9. Gastroenterology. 1994. PMID: 7958678

5

Sialyl-Tn antigen as a marker of colon cancer risk in ulcerative colitis: relation to dysplasia and DNA aneuploidy.

Karlén P, Young E, Broström O, Löfberg R, Tribukait B, Ost K, Bodian C, Itzkowitz S. Karlén P, et al. Gastroenterology. 1998 Dec;115(6):1395-404. doi: 10.1016/s0016-5085(98)70018-6. Gastroenterology. 1998. PMID: 9834267

6

Increased risk of cancer in ulcerative colitis: a population-based cohort study.

Karlén P, Löfberg R, Broström O, Leijonmarck CE, Hellers G, Persson PG. Karlén P, et al. Am J Gastroenterol. 1999 Apr;94(4):1047-52. doi: 10.1111/j.1572-0241.1999.01012.x. Am J Gastroenterol. 1999. PMID: 10201481

7

Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study.

Askling J, Dickman PW, Karlén P, Broström O, Lapidus A, Löfberg R, Ekbom A. Askling J, et al. Among authors: karlen p. Lancet. 2001 Jan 27;357(9252):262-6. doi: 10.1016/S0140-6736(00)03612-6. Lancet. 2001. PMID: 11214128

8

Family history as a risk factor for colorectal cancer in inflammatory bowel disease.

Askling J, Dickman PW, Karlén P, Broström O, Lapidus A, Löfberg R, Ekbom A. Askling J, et al. Among authors: karlen p. Gastroenterology. 2001 May;120(6):1356-62. doi: 10.1053/gast.2001.24052. Gastroenterology. 2001. PMID: 11313305

9

Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County.

Ljung T, Karlén P, Schmidt D, Hellström PM, Lapidus A, Janczewska I, Sjöqvist U, Löfberg R. Ljung T, et al. Among authors: karlen p. Gut. 2004 Jun;53(6):849-53. doi: 10.1136/gut.2003.018515. Gut. 2004. PMID: 15138212 Free PMC article.

10

Risk of haematopoietic cancer in patients with inflammatory bowel disease.

Askling J, Brandt L, Lapidus A, Karlén P, Björkholm M, Löfberg R, Ekbom A. Askling J, et al. Among authors: karlen p. Gut. 2005 May;54(5):617-22. doi: 10.1136/gut.2004.051771. Gut. 2005. PMID: 15831904 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters